Catheter News and Research

RSS

In medicine, a catheter is a tube that can be inserted into a body cavity, duct, or vessel. Catheters . In most uses, a catheter is a thin, flexible tube ("soft" catheter), though in some uses, it is a larger, solid ("hard") catheter. A catheter left inside the body, either temporarily or permanently, may be referred to as an indwelling catheter. A permanently inserted catheter may be referred to as a permcath.

Baylor Plano first hospital to merge MEM software and Epoch platform for atrial fibrillation therapy

Baylor Plano became the first hospital in the world on Friday to merge two highly advanced technologies for atrial fibrillation therapy.

27 Aug 2012

Renal denervation improves depression, QOL and stress in patients with resistant hypertension

Renal sympathetic denervation improves anxiety, depression, quality of life and stress in patients with resistant hypertension, according to research presented at ESC Congress 2012 by Dr Denise Fischer from Saarland University Hospital.

27 Aug 2012

Renal denervation safe and effective in patients with treatment resistant hypertension

Renal denervation leads to significant and sustained blood pressure reduction for up to 18 months in patients with treatment resistant hypertension, according to research presented at ESC Congress 2012.

27 Aug 2012

Study confirms electrical storm as potent risk factor for death and impaired quality of life

Electrical storm (ES) is a potent risk factor for mortality and morbidity, according to research presented today at the ESC Congress 2012 by Dr Federico Guerra from Italy. Data was also presented on which patients are prone to developing ES and how effective current treatments are.

27 Aug 2012

Loyola University Medical Center named among Most Wired Hospitals and Health Systems

Loyola University Medical Center (LUMC) has been named one of the nation's Most Wired Hospitals and Health Systems, according to results of the 2012 Most Wired Survey and Benchmarking Study.

27 Aug 2012

Parachute device improves outcomes in patients with ischemic heart failure

A novel non-invasive device which separates healthy and damaged heart muscle and restores ventricle function improves 3 year outcomes in patients with ischemic heart failure, according to research presented at the ESC Congress 2012.

26 Aug 2012

AcelRx commences third ARX-01 Phase 3 study in post-operative pain

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced dosing of the first patient in the third of three planned Phase 3 studies for ARX-01, the Sufentanil NanoTab PCA System, its novel sublingual patient-controlled analgesia (PCA) system.

24 Aug 2012

Agenda now available for Transcatheter Cardiovascular Therapeutics symposium

TCT 2012 (Transcatheter Cardiovascular Therapeutics), the annual scientific symposium of the Cardiovascular Research Foundation will provide significant clinical research updates to technologies and practices in interventional cardiology that will directly affect patient care.

23 Aug 2012

Endovascular brachytherapy may safely and effectively treat femoropopliteal in-stent stenosis

Placement of an endovascular stent has become a common procedure to successfully reopen blocked arteries. Even so, the treated vessel may once again narrow (restenosis), restricting blood flow. In the femoral and popliteal arteries in the leg, the use of nitinol stents magnifies this problem. About 20 to 40 percent of these stent patients experience restenosis 2 years after angioplasty. Now, an improved radiation technique may provide a safe and effective solution.

22 Aug 2012

Juventas commences treatment in JVS-100 Phase II STOP-HF trial for late stage heart failure

Juventas Therapeutics, a privately-held clinical-stage company developing novel regenerative therapies for treatment of cardiovascular disease, reports treating the first patient in its STOP-HF trial.

20 Aug 2012

Surgeons perform two TAVR procedures at Toledo Hospital

Minimally invasive surgery is one of the biggest trends in health care as a safer alternative to major surgery. One of the newest procedures, approved this year by the Food and Drug Administration, is Transcatheter Aortic Valve Replacement (TAVR).

16 Aug 2012

Special device provides evidence of how bloodstream infections begin

New research may help explain why hundreds of thousands of Americans a year get sick - and tens of thousands die - after bacteria get into their blood. It also suggests why some of those bloodstream infections resist treatment with even the most powerful antibiotics.

16 Aug 2012

UCLA performs first transcatheter aortic valve replacement using new device

UCLA has performed its first transcatheter aortic valve replacement (TAVR), using a new device approved by the U.S. Food and Drug Administration to replace an aortic valve in a patient who was not a candidate for open-heart surgery. The procedure took place August 9th.

16 Aug 2012

Reduce nurses’ burden, reduce in-hospital infections

The rate of “burnout” felt by nurses could be directly related to the rate of hospital-acquired infections via staffing rates, indicate US study results.

13 Aug 2012

New class of polymers resistant to bacterial attachment

Using state-of-the-art technology scientists at The University of Nottingham have discovered a new class of polymers that are resistant to bacterial attachment. These new materials could lead to a significant reduction in hospital infections and medical device failures.

13 Aug 2012

Biosense Webster launches new CARTO 3 Multi-Electrode Mapping Version

Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced the launch of the new CARTO 3 MEM (Multi-Electrode Mapping) Version in the United States.

13 Aug 2012

Scientists discover new class of polymers that are resistant to bacterial attachment

13 Aug 2012

Covalon’s IV Clear antimicrobial clear silicone dressing to be presented at FIME 2012

Covalon Technologies Ltd., an advanced medical technologies company, today announced that it is presenting its latest breakthrough antimicrobial products, including the recently United States FDA cleared IV Clear at the 2012 FIME International Medical Expo from August 8 to 10 in Miami Beach, Florida.

9 Aug 2012

FDA approves Codman’s MEDSTREAM Programmable Infusion System

Codman & Shurtleff, Inc. (Codman), the global neurological device company, has received U.S. Food and Drug Administration (FDA) approval through a PMA supplement for its MEDSTREAM Programmable Infusion System, an implantable infusion pump and catheter system used in the treatment of spasticity, a movement disorder often caused by stroke, cerebral palsy, multiple sclerosis or spinal cord injury.

9 Aug 2012

Neutral-pressure IV connector eliminates catheter-related bloodstream infections in cancer patients

A neutral-pressure IV needleless connector was associated with complete elimination of catheter-related bloodstream infections (CRBSI) in a successful device trial at a large cancer center in the six-month period following implementation of the device.

8 Aug 2012

Catheter News and Research

Further Reading

Baylor Plano first hospital to merge MEM software and Epoch platform for atrial fibrillation therapy

Renal denervation improves depression, QOL and stress in patients with resistant hypertension

Renal denervation safe and effective in patients with treatment resistant hypertension

Study confirms electrical storm as potent risk factor for death and impaired quality of life

Loyola University Medical Center named among Most Wired Hospitals and Health Systems

Parachute device improves outcomes in patients with ischemic heart failure

AcelRx commences third ARX-01 Phase 3 study in post-operative pain

Agenda now available for Transcatheter Cardiovascular Therapeutics symposium

Endovascular brachytherapy may safely and effectively treat femoropopliteal in-stent stenosis

Juventas commences treatment in JVS-100 Phase II STOP-HF trial for late stage heart failure

Surgeons perform two TAVR procedures at Toledo Hospital

Special device provides evidence of how bloodstream infections begin

UCLA performs first transcatheter aortic valve replacement using new device

Reduce nurses’ burden, reduce in-hospital infections

New class of polymers resistant to bacterial attachment

Biosense Webster launches new CARTO 3 Multi-Electrode Mapping Version

Scientists discover new class of polymers that are resistant to bacterial attachment

Covalon’s IV Clear antimicrobial clear silicone dressing to be presented at FIME 2012

FDA approves Codman’s MEDSTREAM Programmable Infusion System

Neutral-pressure IV connector eliminates catheter-related bloodstream infections in cancer patients

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News